We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here's How Much a $1000 Investment in Elevance Health Made 10 Years Ago Would Be Worth Today
Read MoreHide Full Article
How much a stock's price changes over time is important for most investors, since price performance can both impact your investment portfolio and help you compare investment results across sectors and industries.
Another thing that can drive investing is the fear of missing out, or FOMO. This particularly applies to tech giants and popular consumer-facing stocks.
What if you'd invested in Elevance Health (ELV - Free Report) ten years ago? It may not have been easy to hold on to ELV for all that time, but if you did, how much would your investment be worth today?
Elevance Health's Business In-Depth
With that in mind, let's take a look at Elevance Health's main business drivers.
Based in Indianapolis, IN, Elevance Health is one of the largest publicly traded health insurers in the United States, in terms of membership. The company was previously named Anthem, Inc. Effective Jun 27, 2022, the corporate name was changed to Elevance Health and began trading under the ticker “ELV” on Jun 28. Before Anthem, it was named WellPoint Inc.
The company is an independent licensee of the Blue Cross Blue Shield Association (BCBSA). As of Jun 30, 2022, it catered to 47 million medical members through its affiliated health plans. With the latest name change the company announced its intention to rejig its brand portfolio. The company is expected to organize its brand portfolio into Anthem Blue Cross/Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon core got-to-market brands.
Elevance Health currently operates through four reportable segments:
Government Business (52.7% of 2021 Revenues): The segment consists of the Medicaid, Medicare businesses and National Government Services. It offers services to the federal government through the FEHB program.
Commercial & Specialty Business (24.7%): The segment covers the Group risk-based and fee-based, Individual and BlueCard businesses. It offers administrative managed care services to the fee=based clients. Furthermore, this unit offers products like vision, dental, life, disability and supplemental health insurance benefits.
IngenioRx (16.1%): The IngenioRx segment includes the company’s PBM business, which began its operations in the second quarter of 2019. IngenioRx markets and offers PBM services to health plan clients as well as external customers. The PBM service portfolio incorporates services like pharmacy networks, formulary management, prescription drug database, member services and others.
Other (6.5%): This comprises Carelon, the Diversified Business Group, which focuses on reducing expenses and improve healthcare quality. It builds new care delivery and payment models to serve people with chronic conditions.
Bottom Line
Anyone can invest, but building a successful investment portfolio requires research, patience, and a little bit of risk. So, if you had invested in Elevance Health ten years ago, you're likely feeling pretty good about your investment today.
A $1000 investment made in October 2012 would be worth $8,705.66, or a 770.57% gain, as of October 27, 2022, according to our calculations. Investors should note that this return excludes dividends but includes price increases.
The S&P 500 rose 171.30% and the price of gold increased -6.65% over the same time frame in comparison.
Analysts are forecasting more upside for ELV too.
Elevance Health's third-quarter earnings beat estimates. Its shares have outperformed its industry in a year. Its improving top-line can be attributed to premium rate increases and higher memberships. Acquisitions and collaborations have enabled the company to strengthen its business portfolio. Its well-performing Medicare and Medicaid businesses, coupled with several contract wins, are expected to drive its membership going ahead. Adjusted net income is anticipated to be more than $28.95 per share, higher than the prior outlook of greater than $28.70. However, the company's escalating costs continue to put pressure on margins. Declining cash flows are also concerning. Its balance sheet with a massive debt of more than $21 billion can affect financial flexibility. As such, the stock warrants a cautious stance.
The stock is up 17.76% over the past four weeks, and no earnings estimate has gone lower in the past two months, compared to 7 higher, for fiscal 2022. The consensus estimate has moved up as well.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Here's How Much a $1000 Investment in Elevance Health Made 10 Years Ago Would Be Worth Today
How much a stock's price changes over time is important for most investors, since price performance can both impact your investment portfolio and help you compare investment results across sectors and industries.
Another thing that can drive investing is the fear of missing out, or FOMO. This particularly applies to tech giants and popular consumer-facing stocks.
What if you'd invested in Elevance Health (ELV - Free Report) ten years ago? It may not have been easy to hold on to ELV for all that time, but if you did, how much would your investment be worth today?
Elevance Health's Business In-Depth
With that in mind, let's take a look at Elevance Health's main business drivers.
Based in Indianapolis, IN, Elevance Health is one of the largest publicly traded health insurers in the United States, in terms of membership. The company was previously named Anthem, Inc. Effective Jun 27, 2022, the corporate name was changed to Elevance Health and began trading under the ticker “ELV” on Jun 28. Before Anthem, it was named WellPoint Inc.
The company is an independent licensee of the Blue Cross Blue Shield Association (BCBSA). As of Jun 30, 2022, it catered to 47 million medical members through its affiliated health plans. With the latest name change the company announced its intention to rejig its brand portfolio. The company is expected to organize its brand portfolio into Anthem Blue Cross/Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon core got-to-market brands.
Elevance Health currently operates through four reportable segments:
Government Business (52.7% of 2021 Revenues): The segment consists of the Medicaid, Medicare businesses and National Government Services. It offers services to the federal government through the FEHB program.
Commercial & Specialty Business (24.7%): The segment covers the Group risk-based and fee-based, Individual and BlueCard businesses. It offers administrative managed care services to the fee=based clients. Furthermore, this unit offers products like vision, dental, life, disability and supplemental health insurance benefits.
IngenioRx (16.1%): The IngenioRx segment includes the company’s PBM business, which began its operations in the second quarter of 2019. IngenioRx markets and offers PBM services to health plan clients as well as external customers. The PBM service portfolio incorporates services like pharmacy networks, formulary management, prescription drug database, member services and others.
Other (6.5%): This comprises Carelon, the Diversified Business Group, which focuses on reducing expenses and improve healthcare quality. It builds new care delivery and payment models to serve people with chronic conditions.
Bottom Line
Anyone can invest, but building a successful investment portfolio requires research, patience, and a little bit of risk. So, if you had invested in Elevance Health ten years ago, you're likely feeling pretty good about your investment today.
A $1000 investment made in October 2012 would be worth $8,705.66, or a 770.57% gain, as of October 27, 2022, according to our calculations. Investors should note that this return excludes dividends but includes price increases.
The S&P 500 rose 171.30% and the price of gold increased -6.65% over the same time frame in comparison.
Analysts are forecasting more upside for ELV too.
Elevance Health's third-quarter earnings beat estimates. Its shares have outperformed its industry in a year. Its improving top-line can be attributed to premium rate increases and higher memberships. Acquisitions and collaborations have enabled the company to strengthen its business portfolio. Its well-performing Medicare and Medicaid businesses, coupled with several contract wins, are expected to drive its membership going ahead. Adjusted net income is anticipated to be more than $28.95 per share, higher than the prior outlook of greater than $28.70. However, the company's escalating costs continue to put pressure on margins. Declining cash flows are also concerning. Its balance sheet with a massive debt of more than $21 billion can affect financial flexibility. As such, the stock warrants a cautious stance.
The stock is up 17.76% over the past four weeks, and no earnings estimate has gone lower in the past two months, compared to 7 higher, for fiscal 2022. The consensus estimate has moved up as well.